10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,550,220 | +22.0% | 81,312 | -10.1% | 0.04% | -13.6% |
| Q3 2023 | $3,730,609 | -29.4% | 90,439 | -4.5% | 0.04% | -4.3% |
| Q2 2023 | $5,286,708 | -3.3% | 94,676 | -3.4% | 0.05% | -13.2% |
| Q1 2023 | $5,469,094 | +42.6% | 98,030 | -6.8% | 0.05% | +32.5% |
| Q4 2022 | $3,834,290 | -99.7% | 105,222 | +96.0% | 0.04% | +135.3% |
| Q3 2022 | $1,529,262,000 | +57760.8% | 53,696 | -8.1% | 0.02% | -34.6% |
| Q2 2022 | $2,643,000 | -42.6% | 58,417 | -3.6% | 0.03% | -27.8% |
| Q1 2022 | $4,608,000 | -76.6% | 60,570 | -54.2% | 0.04% | -50.7% |
| Q4 2021 | $19,700,000 | +1257.7% | 132,246 | +1226.8% | 0.07% | +386.7% |
| Q3 2021 | $1,451,000 | -16.0% | 9,967 | +13.0% | 0.02% | -21.1% |
| Q2 2021 | $1,728,000 | +68.8% | 8,823 | +56.0% | 0.02% | +46.2% |
| Q1 2021 | $1,024,000 | – | 5,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |